-
Green Thumb Industries has opened RISE Dispensary Cape Coral in Florida, its 25th RISE location in the state and more than 120th store nationwide, offering a wide range of branded cannabis products to medical patients across Lee County with extended weekly operating hours.
-
This latest opening underscores Green Thumb's expanding retail footprint in Florida, reinforcing the company's dual focus on branded consumer products and a growing national dispensary network.
-
We'll now examine how this additional Florida dispensary, as the company's 25th location in the state, influences Green Thumb's broader investment narrative.
The future of work is here. Discover the 91 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
Green Thumb Industries Investment Narrative Recap
To own Green Thumb, you need to believe its mix of retail stores and branded products can keep generating cash even as cannabis prices stay under pressure and federal rules remain uncertain. The Cape Coral opening adds another spoke to the Florida wheel, but on its own it does not materially change the near term tug of war between store expansion as a catalyst and the risk of rising costs and potential overextension.
The most relevant recent update here is management's guidance around flat to slightly down near term revenue amid pricing pressure, even as it keeps opening stores like Cape Coral. That contrast matters: adding dispensaries into a backdrop of weaker same store trends and higher SG&A makes investors focus less on headline store counts and more on whether each new Florida location can scale efficiently and support margins.
Yet against this growth story, you still need to weigh the rising SG&A burden that investors should be aware of...
Read the full narrative on Green Thumb Industries (it's free!)
Green Thumb Industries' narrative projects $1.4 billion revenue and $22.9 million earnings by 2029. This implies 4.9% yearly revenue growth but a decline of $98.3 million in earnings from $121.2 million today.
Uncover how Green Thumb Industries' forecasts yield a CA$20.31 fair value , a 115% upside to its current price.
Exploring Other Perspectives
Compared with consensus, the lowest analysts are far more cautious, projecting earnings to fall to about US$49.1 million by 2029, so you may want to compare their cost focused concerns against the Schedule III tax relief narrative and decide which better fits how you see Green Thumb after the Cape Coral expansion.
Explore 6 other fair value estimates on Green Thumb Industries - why the stock might be worth just CA$14.11!
Decide For Yourself
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
-
A great starting point for your Green Thumb Industries research is our analysis highlighting 5 key rewards and 1 important warning sign that could impact your investment decision.
-
Our free Green Thumb Industries research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Green Thumb Industries' overall financial health at a glance.
Contemplating Other Strategies?
Opportunities like this don't last. These are today's most promising picks. Check them out now:
-
Find 8 companies with promising cash flow potential yet trading below their fair value .
-
Uncover the next big thing with 18 elite penny stocks that balance risk and reward.
-
AI is about to change healthcare. These 7 stocks are working on everything from early diagnostics to drug discovery . The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include GTII.cnsx .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
